{"transactions":[{"id":774620,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-18T17:36:18.000Z","date":"2026-05-15","kind":"grant","planned":false,"acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall fully vest on May 15, 2027, subject to continued service through the vesting date."}],"balance_after":3300,"derivative":{"underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001204663-26-000007","document":"wk-form4_1779140175.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000120466326000007/wk-form4_1779140175.xml","form_type":"4"}},{"id":795392,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-01T20:30:51.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":false,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":3403},"source":{"system":"sec-edgar","filing":"0001204663-26-000005","document":"wk-form4_1777667448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000120466326000005/wk-form4_1777667448.xml","form_type":"4"}},{"id":795391,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-01T20:30:51.000Z","date":"2026-04-30","kind":"exercise","planned":false,"acquired":true,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8947,"source":{"system":"sec-edgar","filing":"0001204663-26-000005","document":"wk-form4_1777667448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000120466326000005/wk-form4_1777667448.xml","form_type":"4"}},{"id":825148,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-30T23:37:24.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":false,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Common Stock Upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are fully vested."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001204663-26-000003","document":"wk-form4_1774913840.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000120466326000003/wk-form4_1774913840.xml","form_type":"4"}},{"id":825147,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-30T23:37:24.000Z","date":"2026-03-27","kind":"exercise","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5544,"source":{"system":"sec-edgar","filing":"0001204663-26-000003","document":"wk-form4_1774913840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000120466326000003/wk-form4_1774913840.xml","form_type":"4"}},{"id":1147166,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-15T20:20:56.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs fully vested on May 13, 2025."}],"balance_after":0,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":3564},"source":{"system":"sec-edgar","filing":"0001628280-25-025946","document":"wk-form4_1747340448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000162828025025946/wk-form4_1747340448.xml","form_type":"4"}},{"id":1147165,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-15T20:20:56.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3564,"source":{"system":"sec-edgar","filing":"0001628280-25-025946","document":"wk-form4_1747340448.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000162828025025946/wk-form4_1747340448.xml","form_type":"4"}},{"id":1160901,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-05-02T20:18:34.000Z","date":"2025-04-30","kind":"grant","planned":false,"acquired":true,"shares":3403,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on April 30, 2026, subject to continued service through the vesting date."}],"balance_after":3403,"derivative":{"expiration_date":"2035-04-30","underlying":"Common Stock","underlying_shares":3403},"source":{"system":"sec-edgar","filing":"0001628280-25-021844","document":"wk-form4_1746217108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000162828025021844/wk-form4_1746217108.xml","form_type":"4"}},{"id":1515747,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:37:05.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":1980,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall fully vest on March 27, 2026, subject to continued service through the vesting date."}],"balance_after":5544,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1980},"source":{"system":"sec-edgar","filing":"0001127602-24-015468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000112760224015468/form4.xml","form_type":"4"}},{"id":1515746,"issuer":{"id":1645,"kind":"organization","name":"Solventum Corp","symbol":"SOLV"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-15T20:37:05.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":3564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock unit (\"RSU\") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall fully vest on May 13, 2025, subject to continued service through the vesting date."}],"balance_after":3564,"derivative":{"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":3564},"source":{"system":"sec-edgar","filing":"0001127602-24-015468","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1204663/000112760224015468/form4.xml","form_type":"4"}},{"id":2513939,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2021-11-15T13:04:13.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":3709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 11, 2022, except if the 2022 Annual Meeting of Shareholders is prior to November 11, 2022, then the restricted share units will vest on the date of the 2022 Annual Meeting of Shareholders."}],"balance_after":11138,"source":{"system":"sec-edgar","filing":"0000721371-21-000128","document":"wf-form4_163698143910876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137121000128/wf-form4_163698143910876.xml","form_type":"4"}},{"id":2987541,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2020-11-10T21:40:35.000Z","date":"2020-11-09","kind":"grant","acquired":true,"shares":3339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 9, 2021, except if the 2021 Annual Meeting of Shareholders is prior to November 9, 2021, then the restricted share units will vest on the date of the 2021 Annual Meeting of Shareholders."}],"balance_after":7429,"source":{"system":"sec-edgar","filing":"0000721371-20-000157","document":"wf-form4_160504442270493.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137120000157/wf-form4_160504442270493.xml","form_type":"4"}},{"id":3361975,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:24.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of   Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-001363","document":"form4-11222019_071111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001363/form4-11222019_071111.xml","form_type":"4"}},{"id":3361974,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-11-22T07:30:24.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of   Celgene common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the Effective Time, these restricted stock units were assumed by BMS and converted into restricted stock units relating to BMS common stock and CVRs in accordance with the methodology and exchange ratio set forth in the Merger Agreement and became vested.  The converted restricted stock units will be settled as promptly as practicable following the Effective Time."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001415889-19-001363","document":"form4-11222019_071111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001363/form4-11222019_071111.xml","form_type":"4"}},{"id":3361973,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:24.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-19-001363","document":"form4-11222019_071111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001363/form4-11222019_071111.xml","form_type":"4"}},{"id":3361972,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-22T07:30:24.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was fully exercisable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Upon the Effective Time, these stock options were assumed by BMS and converted into options relating to BMS common stock (plus a payment of CVRs, in some cases) in accordance with the methodology and exchange ratio set forth in the Merger Agreement."}],"balance_after":0,"derivative":{"exercise_price":91.98,"expiration_date":"2028-02-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-19-001363","document":"form4-11222019_071111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001363/form4-11222019_071111.xml","form_type":"4"}},{"id":3361971,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-22T07:30:24.000Z","date":"2019-11-20","kind":"disposition_to_issuer","acquired":false,"shares":5575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition in connection with the Agreement and Plan of Merger (the \"Merger Agreement\") dated January 2, 2019, by and among Celgene Corporation (\"Celgene\"), Bristol-Myers Squibb Company (\"BMS\"), and Burgundy Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of BMS (\"Merger Sub\"), pursuant to which Merger Sub will merge with and into Celgene, with Celgene surviving as a direct wholly owned subsidiary of BMS and upon the effective time of such merger (the \"Effective Time\"), each share of Celgene common stock was converted into the right to receive (i) $50.00 in cash, (ii) one share of BMS common stock, and (iii) one contingent value right (\"CVR\") issued by BMS subject to and in accordance with the CVR agreement, dated November 20, 2019, by and between BMS and the Equiniti Trust Company."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-19-001363","document":"form4-11222019_071111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919001363/form4-11222019_071111.xml","form_type":"4"}},{"id":3373761,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-11-13T21:17:35.000Z","date":"2019-11-12","kind":"grant","acquired":true,"shares":3424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on November 12, 2020, except if the 2020 Annual Meeting of Shareholders is prior to November 12, 2020, then the restricted share units will vest on the date of the 2020 Annual Meeting of Shareholders."}],"balance_after":4090,"source":{"system":"sec-edgar","filing":"0000721371-19-000147","document":"wf-form4_157367983502583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137119000147/wf-form4_157367983502583.xml","form_type":"4"}},{"id":3413282,"issuer":{"id":3014,"kind":"organization","name":"CARDINAL HEALTH INC"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2019-09-17T12:35:49.000Z","date":"2019-09-15","kind":"grant","acquired":true,"shares":666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted share units that will vest on September 15, 2020."}],"balance_after":666,"source":{"system":"sec-edgar","filing":"0000721371-19-000106","document":"wf-form4_156872373403897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/721371/000072137119000106/wf-form4_156872373403897.xml","form_type":"4"}},{"id":3501338,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-05T16:05:33.000Z","date":"2019-06-03","kind":"grant","acquired":true,"shares":4756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest in three annual installments as follows: 1,585 shares on June 3, 2020; 1,585 shares on June 3, 2021; and 1,586 shares on June 3, 2022.  Vested shares will be delivered to the reporting person promptly after the vesting date."}],"balance_after":4756,"derivative":{"underlying":"Common Stock","underlying_shares":4756},"source":{"system":"sec-edgar","filing":"0001415889-19-000664","document":"form4-06052019_040620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588919000664/form4-06052019_040620.xml","form_type":"4"}},{"id":3851328,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-07T16:17:19.000Z","date":"2018-08-07","kind":"purchase","acquired":true,"shares":5575,"price":89.731,"value":500250.325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased by the reporting person in multiple transactions at prices ranging from 89.725 to $89.732, inclusive. The reporting person undertakes to provide Celgene Corporation (the \"Company\"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."}],"balance_after":5575,"source":{"system":"sec-edgar","filing":"0001415889-18-001232","document":"form4-08072018_010858.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918001232/form4-08072018_010858.xml","form_type":"4"}},{"id":3857376,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2018-08-01T20:35:28.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":260.5786,"price":99.16,"value":25838.973976,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":24627.5326,"derivative":{"underlying":"Common Stock","underlying_shares":260.5786},"source":{"system":"sec-edgar","filing":"0001562180-18-003450","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018003450/primarydocument.xml","form_type":"4"}},{"id":3893140,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2018-06-15T16:24:27.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":1454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered promptly to the reporting person on June 13, 2022 at the reporting person's election to defer receipt of such shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in three annual installments as follows: 484 shares on June 13, 2019; 485 shares on June 13, 2020; and 485 shares on June 13, 2021. Vested shares will be delivered promptly to the reporting person on June 13, 2022 at the reporting person's election to defer receipt of such shares."}],"balance_after":1454,"derivative":{"underlying":"Common Stock","underlying_shares":1454},"source":{"system":"sec-edgar","filing":"0001415889-18-000942","document":"form4-06152018_010611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000942/form4-06152018_010611.xml","form_type":"4"}},{"id":3893139,"issuer":{"id":15781,"kind":"organization","name":"CELGENE CORP /DE/"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T16:24:27.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":13266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was issued pursuant to the Company's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option is immediately exercisable and will vest on the earlier of June 13, 2019 or the day preceding the date of the next annual stockholder meeting."}],"balance_after":13266,"derivative":{"exercise_price":77.38,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13266},"source":{"system":"sec-edgar","filing":"0001415889-18-000942","document":"form4-06152018_010611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/816284/000141588918000942/form4-06152018_010611.xml","form_type":"4"}},{"id":3949037,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-03T21:51:04.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":1824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":45358.7246,"source":{"system":"sec-edgar","filing":"0001562180-18-002202","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218018002202/primarydocument.xml","form_type":"4"}},{"id":4116518,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":23088,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":219.555,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":23088},"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116517,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":11145,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":136.37,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":11145},"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116516,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":32022,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":168.865,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":32022},"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116515,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":29855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock."}],"balance_after":0,"derivative":{"exercise_price":186.425,"expiration_date":"2025-12-09","underlying":"Common Stock","underlying_shares":29855},"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116514,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":6018.306,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"401(k) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Includes 6,018.306 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116513,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":37129,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Includes 37,129 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program (\"MSPP\").  In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116512,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":29823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 29,823 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) (\"PLTIP\"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units."}],"balance_after":37129,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116511,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":17025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Includes 17,025 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units."}],"balance_after":66952,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116510,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"disposition_to_issuer","acquired":false,"shares":0.29,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Includes 0.29 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration."}],"balance_after":83977,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116509,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":11258,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Includes 11,258 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger."}],"balance_after":83977.29,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4116508,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2018-01-03T20:18:21.000Z","date":"2017-12-29","kind":"grant","acquired":true,"shares":29823,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the \"Merger\") of Lambda Corp. (\"Lambda\") with and into C. R. Bard, Inc. (\"Bard\") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company (\"BD\") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the \"Merger Consideration\"). All of the transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Includes 29,823 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) (\"PLTIP\"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units."}],"balance_after":72719.29,"source":{"system":"sec-edgar","filing":"0001225208-18-000499","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520818000499/doc4.xml","form_type":"4"}},{"id":4168591,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2017-11-09T14:16:18.000Z","date":"2017-11-07","kind":"exercise","acquired":false,"shares":33435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Of this option grant 33,435 options fully vested and the remaining options vest on December 11, 2017."}],"balance_after":11145,"derivative":{"exercise_price":136.37,"expiration_date":"2023-12-11","underlying":"Common Stock","underlying_shares":33435},"source":{"system":"sec-edgar","filing":"0001225208-17-017130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817017130/doc4.xml","form_type":"4"}},{"id":4168590,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-11-09T14:16:18.000Z","date":"2017-11-07","kind":"sale","acquired":false,"shares":33435,"price":333.3095,"value":11144203.1325,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average sales price for price increments ranging from $332.92 to $333.68. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":42896.29,"source":{"system":"sec-edgar","filing":"0001225208-17-017130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817017130/doc4.xml","form_type":"4"}},{"id":4168589,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-11-09T14:16:18.000Z","date":"2017-11-07","kind":"exercise","acquired":true,"shares":33435,"price":136.37,"value":4559530.95,"ownership":{"direct":true},"balance_after":76331.29,"source":{"system":"sec-edgar","filing":"0001225208-17-017130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817017130/doc4.xml","form_type":"4"}},{"id":4196563,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2017-10-03T19:54:57.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":233.5721,"price":96.33,"value":22500.000393,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":24366.954,"derivative":{"underlying":"Common Stock","underlying_shares":233.5721},"source":{"system":"sec-edgar","filing":"0001562180-17-003163","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017003163/primarydocument.xml","form_type":"4"}},{"id":4266695,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2017-07-05T16:38:58.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":238.3727,"price":94.39,"value":22499.999153,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":24097.4198,"derivative":{"underlying":"Common Stock","underlying_shares":238.3727},"source":{"system":"sec-edgar","filing":"0001562180-17-002372","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017002372/primarydocument.xml","form_type":"4"}},{"id":4336641,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-03T18:56:23.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":1697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of restricted stock units will vest in full after 12 months and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":43412.1785,"source":{"system":"sec-edgar","filing":"0001562180-17-001688","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001688/primarydocument.xml","form_type":"4"}},{"id":4363888,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2017-04-04T19:17:48.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":275.4315,"price":81.69,"value":22499.999235,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":23826.1067,"derivative":{"underlying":"Common Stock","underlying_shares":275.4315},"source":{"system":"sec-edgar","filing":"0001562180-17-001425","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017001425/primarydocument.xml","form_type":"4"}},{"id":4447780,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:23.000Z","date":"2017-02-14","kind":"sale","acquired":false,"shares":14091,"price":240.4946,"value":3388809.4086,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price for price increments ranging from $240.31 to $241.00. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":42896.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003407/doc4.xml","form_type":"4"}},{"id":4447779,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:23.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":5382,"price":240.47,"value":1294209.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":56987.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003407/doc4.xml","form_type":"4"}},{"id":4447778,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:23.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":5335,"price":240.47,"value":1282907.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":62369.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003407/doc4.xml","form_type":"4"}},{"id":4447777,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-15T16:58:23.000Z","date":"2017-02-13","kind":"tax_withholding","acquired":false,"shares":1055,"price":240.47,"value":253695.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":68978.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003407/doc4.xml","form_type":"4"}},{"id":4453242,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-14T15:20:39.000Z","date":"2017-02-13","kind":"sale","acquired":false,"shares":1274,"price":239.9985,"value":305758.089,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for price increments ranging from $239.88 to $240.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":68759.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003177/doc4.xml","form_type":"4"}},{"id":4453241,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-14T15:20:39.000Z","date":"2017-02-10","kind":"tax_withholding","acquired":false,"shares":1098,"price":239.925,"value":263437.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to pay taxes upon vesting of restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":70033.29,"source":{"system":"sec-edgar","filing":"0001225208-17-003177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817003177/doc4.xml","form_type":"4"}},{"id":4459000,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-09","kind":"sale","acquired":false,"shares":14081,"price":239.5381,"value":3372935.9861,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents the weighted average sales price for price increments ranging from $238.90 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":71131.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458999,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-09","kind":"sale","acquired":false,"shares":200,"price":239.98,"value":47996.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":85212.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458998,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-08","kind":"tax_withholding","acquired":false,"shares":11136,"price":236.68,"value":2635668.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":85412.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458997,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":1844,"price":164.843,"value":303970.492,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":96548.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458996,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":4303,"price":235.49,"value":1013313.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program."}],"balance_after":94704.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458995,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":6788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019."}],"balance_after":90401.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4458994,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2017-02-10T18:23:05.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":22023,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."}],"balance_after":83613.29,"source":{"system":"sec-edgar","filing":"0001225208-17-002829","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520817002829/doc4.xml","form_type":"4"}},{"id":4506063,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2017-01-04T19:57:52.000Z","date":"2016-12-30","kind":"grant","acquired":true,"shares":264.0845,"price":85.2,"value":22499.9994,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":23514.546,"derivative":{"underlying":"Common Stock","underlying_shares":264.0845},"source":{"system":"sec-edgar","filing":"0001562180-17-000147","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000156218017000147/primarydocument.xml","form_type":"4"}},{"id":4520136,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2016-12-16T15:35:52.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":23088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vest in four equal annual installments beginning on December 14, 2017."}],"balance_after":23088,"derivative":{"exercise_price":219.555,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":23088},"source":{"system":"sec-edgar","filing":"0001225208-16-043398","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043398/doc4.xml","form_type":"4"}},{"id":4523273,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Option (Right to Buy)","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"exercise","acquired":false,"shares":11190,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Options fully vested and are currently exercisable."}],"balance_after":0,"derivative":{"exercise_price":97.685,"expiration_date":"2022-12-12","underlying":"Common Stock","underlying_shares":11190},"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4523272,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":7418,"price":219.6679,"value":1629496.4822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sales price for price increments ranging from $219.16 to $220.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":61590.29,"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4523271,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":2422,"price":220.3514,"value":533691.0908,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sales price for price increments ranging from $220.17 to $220.77. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":69008.29,"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4523270,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":1000,"price":218.8241,"value":218824.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price for price increments ranging from $218.12 to $219.10. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":71430.29,"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4523269,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"sale","acquired":false,"shares":350,"price":217.2757,"value":76046.495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price for price increments ranging from $217.05 to $217.81. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4."}],"balance_after":72430.29,"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4523268,"issuer":{"id":170698,"kind":"organization","name":"BARD C R INC /NJ/","symbol":"BCR"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true,"officer":true,"officer_title":"Vice Chairman, Pres. and COO"}}],"security":"Common Stock","published_at":"2016-12-14T12:10:40.000Z","date":"2016-12-12","kind":"exercise","acquired":true,"shares":11190,"price":97.685,"value":1093095.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan."}],"balance_after":72780.29,"source":{"system":"sec-edgar","filing":"0001225208-16-043154","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/9892/000122520816043154/doc4.xml","form_type":"4"}},{"id":4589057,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46379,"kind":"person","name":"WEILAND JOHN H","position":1,"cik":"0001204663","reported_name":"WEILAND JOHN H","relationship":{"director":true}}],"security":"Phantom Stock Unit","published_at":"2016-10-04T19:07:43.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":303.5618,"price":74.12,"value":22500.000616,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects additional shares purchased through dividend reinvestments based on most recent plan statement."}],"balance_after":23176.1364,"derivative":{"underlying":"Common Stock","underlying_shares":303.5618},"source":{"system":"sec-edgar","filing":"0001225208-16-039977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000122520816039977/doc4.xml","form_type":"4"}}]}